• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bridging the Gap: Insights from the AIZANOI Study on Low-Density Lipoprotein-Cholesterol Management in Türkiye.

作者信息

Kayıkçıoğlu Meral

机构信息

Department of Cardiology, Ege University Faculty of Medicine, İzmir, Türkiye.

出版信息

Anatol J Cardiol. 2024 Jun;28(6):283-285. doi: 10.14744/AnatolJCardiol.2024.4607.

DOI:10.14744/AnatolJCardiol.2024.4607
PMID:38829259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168706/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d9/11168706/dce5e8b7121b/ajc-28-6-283_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d9/11168706/ce1d435ebba8/ajc-28-6-283_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d9/11168706/dce5e8b7121b/ajc-28-6-283_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d9/11168706/ce1d435ebba8/ajc-28-6-283_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d9/11168706/dce5e8b7121b/ajc-28-6-283_f002.jpg

相似文献

1
Bridging the Gap: Insights from the AIZANOI Study on Low-Density Lipoprotein-Cholesterol Management in Türkiye.缩小差距：来自AIZANOI研究的关于土耳其低密度脂蛋白胆固醇管理的见解
Anatol J Cardiol. 2024 Jun;28(6):283-285. doi: 10.14744/AnatolJCardiol.2024.4607.
2
High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol.高密度脂蛋白亚组分及内皮脂肪酶对健康土耳其人群的影响：在高密度脂蛋白胆固醇水平较低地区的一项研究
Scand J Clin Lab Invest. 2014 Jun;74(4):278-84. doi: 10.3109/00365513.2013.879992. Epub 2014 Jan 30.
3
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.以高密度脂蛋白胆固醇水平低为特征的人群中血脂异常的风险判定
Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7.
4
[Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review].[他汀类药物使用对土耳其低密度脂蛋白胆固醇水平的影响：一项系统评价]
Turk Kardiyol Dern Ars. 2020 Mar;48(2):137-148. doi: 10.5543/tkda.2019.45156.
5
Prevalence of dyslipidemia and associated risk factors in Turkish adults.土耳其成年人血脂异常的流行情况及相关危险因素。
J Clin Lipidol. 2014 Mar-Apr;8(2):206-16. doi: 10.1016/j.jacl.2013.12.011. Epub 2014 Jan 19.
6
Low-density lipoprotein cholesterol versus particle number in middle school children.低密度脂蛋白胆固醇与中学生的颗粒数。
J Pediatr. 2013 Aug;163(2):355-62. doi: 10.1016/j.jpeds.2013.01.012. Epub 2013 Feb 14.
7
Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.评估 LDL 胆固醇<50mg/dL 且非 HDL 胆固醇<80mg/dL 的 2 型糖尿病患者的 LDL 颗粒数分布。
Am J Cardiol. 2012 Sep 1;110(5):662-5. doi: 10.1016/j.amjcard.2012.04.046. Epub 2012 May 22.
8
Serum oxidized low density lipoprotein levels in preeclamptic and normotensive pregnants.子痫前期孕妇和血压正常孕妇的血清氧化型低密度脂蛋白水平
Clin Exp Obstet Gynecol. 2015;42(6):746-8.
9
Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome.大剂量阿托伐他汀与瑞舒伐他汀对急性冠状动脉综合征患者血脂参数、氧化型低密度脂蛋白及枯草溶菌素9型前蛋白转化酶的比较作用
Coron Artery Dis. 2019 Jun;30(4):285-290. doi: 10.1097/MCA.0000000000000715.
10
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.小而密的低密度脂蛋白胆固醇是前瞻性弗雷明汉后代研究中最具致动脉粥样硬化作用的脂蛋白参数。
J Am Heart Assoc. 2021 Feb;10(5):e019140. doi: 10.1161/JAHA.120.019140. Epub 2021 Feb 15.

本文引用的文献

1
Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study.根据风险组和性别差异，使用他汀类药物的患者对当前血脂异常指南的依从性：AIZANOI 研究。
Anatol J Cardiol. 2024 Jun;28(6):273-282. doi: 10.14744/AnatolJCardiol.2024.4218.
2
Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry.心脏病学实践中家族性高胆固醇血症患者二级预防中低密度脂蛋白胆固醇的错误认知与管理：来自EPHESUS注册研究的真实世界证据
J Clin Lipidol. 2023 Nov-Dec;17(6):732-742. doi: 10.1016/j.jacl.2023.09.013. Epub 2023 Sep 29.
3
Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database.
家族性高胆固醇血症成年和儿科患者的临床特征：来自土耳其国家数据库的真实横断面研究。
Atherosclerosis. 2023 Jun;375:9-20. doi: 10.1016/j.atherosclerosis.2023.04.011. Epub 2023 May 5.
4
The landscape of preventive cardiology in Turkey: Challenges and successes.土耳其预防心脏病学的现状：挑战与成就
Am J Prev Cardiol. 2021 Apr 14;6:100184. doi: 10.1016/j.ajpc.2021.100184. eCollection 2021 Jun.
5
Evaluation of perceptions, knowledge and compliance with guidelines in real-life practice: A survey on the under-treatment of hypercholesterolemia.现实生活实践中对指南的认知、知识及依从性评估：一项关于高胆固醇血症治疗不足的调查。
Turk Kardiyol Dern Ars. 2019 Oct;47(7):599-608. doi: 10.5543/tkda.2019.39293.
6
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
7
Rationale, design, and methodology of the Evaluation of Perceptions, Knowledge, and Compliance with the Guidelines in Real Life Practice: A Survey on the Under-treatment of Hypercholesterolemia.现实生活实践中对高胆固醇血症治疗不足的认知、知识与指南依从性评估的基本原理、设计与方法：一项调查
Turk Kardiyol Dern Ars. 2018 Jan;46(1):47-53. doi: 10.5543/tkda.2017.73861.
8
The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.土耳其全国家族性高胆固醇血症登记处的基本原理与设计：A-HIT1和A-HIT2研究
Turk Kardiyol Dern Ars. 2017 Apr;45(3):261-267. doi: 10.5543/tkda.2017.25800.